2018
DOI: 10.1038/s41423-018-0178-9
|View full text |Cite
|
Sign up to set email alerts
|

Inscribing the core memories of killers

Abstract: Inscribing the core memories of killers SJ Dulson et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 8 publications
(11 reference statements)
0
2
0
Order By: Relevance
“…The overall structures of 161519 TriKE in our study and the one designed previously 20 were identical. However, the anti-CD16 and anti-CD19 antibody sequences 16 , 23 used in our study were different from the ones used previously 25 , 26 . In addition, our study used in vivo models to show that 161519 TriKE promoted the proliferation and survival of human NK cells and mediated stronger anti-tumor responses compared with that by 1619 BiKE.…”
Section: Discussionmentioning
confidence: 86%
See 1 more Smart Citation
“…The overall structures of 161519 TriKE in our study and the one designed previously 20 were identical. However, the anti-CD16 and anti-CD19 antibody sequences 16 , 23 used in our study were different from the ones used previously 25 , 26 . In addition, our study used in vivo models to show that 161519 TriKE promoted the proliferation and survival of human NK cells and mediated stronger anti-tumor responses compared with that by 1619 BiKE.…”
Section: Discussionmentioning
confidence: 86%
“…Cold tumors are immunologically ignorant and express minimal or no MHC class-I molecules on the cell surface 7 . They are barely recognized by CD8 + T cells due to the missing/impaired expression of MHC class-I molecules, but they can be detected readily and targeted by NK cells 8 , 9 , 23 . The 161519 TriKE constructed in our studies was a trispecific protein developed for the treatment of B-cell malignancies (CD19-positive cancers) and was designed to redirect NK cells via their activating receptor CD16 to kill target cells expressing CD19.…”
Section: Discussionmentioning
confidence: 99%